PetVivo net loss widens to $10.47 million in FY26; revenue rises to $1.14 million

PetVivo Holdings Inc

PetVivo Holdings Inc

PETV

0.00
  • PetVivo posted fiscal 2026 revenue of USD 1.14 million, with net loss widening to USD 10.47 million.
  • Operating loss widened to USD 9.06 million as total operating expenses rose to USD 9.82 million.
  • Gross profit fell to USD 754,751 as cost of sales climbed to USD 386,856.
  • Health Canada recognized Spryng with OsteoCushion Technology for commercialization in Canada; a launch is expected near end-July.
  • PetVivo.ai beta users reported a 50% to 90% reduction in veterinary customer acquisition costs, with an official commercial launch expected in coming months.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PetVivo Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606291730PRIMZONEFULLFEED9754402) on June 29, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.